275
Views
0
CrossRef citations to date
0
Altmetric
Assessment Procedures

“How Well” and “How Often” questions for birth brachial plexus injury: a validity and reliability of the pediatric upper extremity motor activity log-revised

ORCID Icon, , &
Pages 2192-2198 | Received 21 Dec 2021, Accepted 28 May 2022, Published online: 23 Jun 2022
 

Abstract

Purpose

The pediatric upper extremity motor activity log-revised (PMAL-R) is a structured interview that measures use of the affected arm in daily life in children with unilateral pathologies like hemiparetic cerebral palsy (CP) or birth brachial plexus injury (BBPI). This study investigated validity and test–retest reliability of the PMAL-R in children with BBPI.

Materials and methods

The PMAL-R was administered to parents of 132 children with BBPI between 5 and 9 years for validity, also 98 parents were re-interviewed after 3 weeks to establish test–retest reliability. Its concurrent validity was examined by correlating scores on the PMAL-R How Well (HW) and How Often (HO) scales with Brachial Plexus Outcome Measure (BPOM) and Pediatric Outcomes Data Collection Instrument (PODCI) scores.

Results

PMAL-R scores were strongly correlated with BPOM scores (HW, r = 0.943, p < 0.001; HO, r = 0.897, p < 0.001), also strongly correlated with PODCI (HW, r = 0.799, p < 0.001; HO, r = 0.797, p < 0.001). PMAL-R test–retest reliability (intraclass correlation; HO = 0.997, HW = 0.998) and internal consistency (Cronbach’s a; HO = 0.99, HW = 0.99) were high.

Conclusions

The PMAL-R has good reliability and validity for measuring everyday use of the affected arm with “how often” and “how well” questions in children with BBPI.

    Implications for rehabilitation

  • The pediatric upper extremity motor activity log-revised (PMAL-R) is the first tool to assess both “how often” and “how well” the affected arm is used in unimanual activities in children with BBPI.

  • PMAL-R is a real-world measure providing valuable information about “how often” and “how well” the affected arm is used to guide treatment.

  • PMAL-R is valid in both concurrent and discriminative validity in children with BBPI.

  • PMAL-R is reliable in children with BBPI.

Disclosure statement

The authors report no conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.